Last reviewed · How we verify
NCT05150106
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
trial testing Clinical assessments of laryngeal function in Laryngeal Dystonia in 165 participants. Currently enrolling.
31 August 2027
Quick facts
| Lead sponsor | Massachusetts Eye and Ear Infirmary |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 165 |
| Start date | 7 November 2022 |
| Primary completion | 31 August 2027 |
| Estimated completion | 31 August 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Clinical assessments of laryngeal function
Conditions studied
- Laryngeal Dystonia — all drugs for Laryngeal Dystonia →
- Spasmodic Dysphonia — all drugs for Spasmodic Dysphonia →
- Tremor — all drugs for Tremor →
Sponsor
Massachusetts Eye and Ear Infirmary — full company profile →
Who can join
Adults 18 to 80, any sex, with Laryngeal Dystonia or Spasmodic Dysphonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The researchers will systematically evaluate current and novel clinical voice assessment tools and measures to elucidate distinct clinical phenotypes of those with laryngeal dystonia and voice tremor.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05150106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Laryngeal Dystonia
Currently open trials in the same condition.
- NCT07443891 — Brain Network Changes After Vibro-tactile Stimulation in Laryngeal Dystonia · NA · recruiting
- NCT05506085 — Deep Brain Stimulation for Laryngeal Dystonia: From Mechanism to Optimal Application · recruiting
- NCT05150093 — Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor · NA · recruiting
- NCT04421365 — Brain-Computer Interfaces in Laryngeal Dystonia · NA · recruiting
- NCT05216770 — Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor · EARLY_PHASE1 · recruiting
Other Massachusetts Eye and Ear Infirmary trials
Trials by the same sponsor.
- NCT06926478 — Subconjunctival Humira for Boston Keratoprosthesis · Phase 1 · not yet recruiting
- NCT06425419 — The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy · Phase 1 · not yet recruiting
- NCT07383701 — Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema · Phase 2 · not yet recruiting
- NCT06688578 — Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait · NA · recruiting
- NCT06753916 — ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05150106 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Massachusetts Eye and Ear Infirmary
- Last refreshed: 2 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing